Overview

About this study

The purpose of this study is to assess age-dependent increases in Von Willebrand Factor (VWF) levels in patients with Type 1 Von Willebrand Disease (VWD) and assess whether there is a change in a person’s bleeding symptoms that correlates with VWF levels.  In addition, we will assess whether certain molecular variants in VWF are more likely to be associated with age-dependent increases in VWF and subsequent changes in clinical bleeding.  

Findings from this study will provide us information that will lead to data driven management approaches for our increasingly growing population of patients with Type 1 VWD.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information